KEY FEATURES
| Full Name | Cluster Of Differentiation 86 |
|---|---|
| Synonym | LAB7-2; B7-2; B70; FUN-1; CD28LG2; CD28 Antigen Ligand 2,B7-2 Antigen; CTLA-4 counter-receptor B7.2; B-Lymphocyte Activation Antigen B7-2 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CD86 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CD86. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CD86 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CD86, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CD86. You can calculate the concentration of Human CD86 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CD86 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.54 | 0.84 | 4.84 | 0.58 | 0.92 | 4.44 |
| Standard deviation | 0.03 | 0.05 | 0.18 | 0.03 | 0.05 | 0.19 |
| CV(%) | 5.58 | 5.44 | 3.78 | 5.07 | 5.4 | 4.31 |
RECOVERY
The recovery of Human CD86 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-107 | 99 |
| EDTA plasma (n=8) | 92-107 | 99 |
| Cell culture media (n=8) | 95-110 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CD86 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CD86 ELISA Kits
| CD80 ELISA Kit | publications with CD86 and CD80 |
| CD40 ELISA Kit | publications with CD86 and CD40 |
| CD4 ELISA Kit | publications with CD86 and CD4 |
| CD28 ELISA Kit | publications with CD86 and CD28 |
| CTLA4 ELISA Kit | publications with CD86 and CTLA4 |
| TLR2 ELISA Kit | publications with CD86 and TLR2 |
| TLR9 ELISA Kit | publications with CD86 and TLR9 |
| CD40LG ELISA Kit | publications with CD86 and CD40LG |
| IFNG ELISA Kit | publications with CD86 and IFNG |
Pathways associated with CD86 ELISA Kit
| Adaptive Immune System Pathway | Adaptive Immune System Pathway |
| Allograft Rejection Pathway | Allograft Rejection Pathway |
| Autoimmune Thyroid Disease Pathway | Autoimmune Thyroid Disease Pathway |
| CD28 Co-stimulation Pathway | CD28 Co-stimulation Pathway |
| CD28 Dependent PI3K/Akt Signaling Pathway | CD28 Dependent PI3K/Akt Signaling Pathway |
| CD28 Dependent Vav1 Pathway | CD28 Dependent Vav1 Pathway |
| CTLA4 Inhibitory Signaling Pathway | CTLA4 Inhibitory Signaling Pathway |
Diseases associated with CD86 ELISA Kit
| Necrosis | publications with CD86 and Necrosis |
| Inflammation | publications with CD86 and Inflammation |
| Nervous System Diseases | publications with CD86 and Nervous System Diseases |
| Lung Diseases | publications with CD86 and Lung Diseases |
| Neoplasms, Experimental | publications with CD86 and Neoplasms, Experimental |
| Liver Diseases | publications with CD86 and Liver Diseases |
| Cardiovascular Diseases | publications with CD86 and Cardiovascular Diseases |
| Brain Diseases | publications with CD86 and Brain Diseases |
| Dermatitis, Contact | publications with CD86 and Dermatitis, Contact |
| Kidney Diseases | publications with CD86 and Kidney Diseases |
Organs/Tissues associated with CD86 ELISA Kit
| Blood | publications with CD86 and Blood |
| Spleen | publications with CD86 and Spleen |
| Lymph Node | publications with CD86 and Lymph Node |
| Lung | publications with CD86 and Lung |
| Vascular | publications with CD86 and Vascular |
| Kidney | publications with CD86 and Kidney |
| Brain | publications with CD86 and Brain |
| Thymus | publications with CD86 and Thymus |
| Eye | publications with CD86 and Eye |
| Pancreas | publications with CD86 and Pancreas |